Tianda Pharma Announces 2022/23 Interim Results
HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (“Tianda Pharma” or “the Group”; stock code: 0455.HK) today announced its interim results for the six […]
Tianda Pharmaceuticals Annual Results 2022
HONG KONG, Jun 30, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (Tianda Pharmaceuticals or the Group, stock code: 0455.HK) is pleased to announce its annual results for […]
Traditional Chinese medicine has role to play in managing chronic conditions in S’pore: Ong Ye Kung
SINGAPORE – Traditional Chinese medicine (TCM) has a role to play in managing chronic conditions here and the Ministry of Health (MOH) will continue to support the sector, said Health […]
One of Singapore’s trailblazing clinician scientist to break new ground in China
SINGAPORE – One of Singapore’s trailblazing clinician scientists, Professor Wong Tien Yin, who is medical director of the Singapore National Eye Centre (SNEC), is forging a new path in Beijing, […]
Tianda Pharma Interim Results 2021
HONG KONG, Nov 26, 2021 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (Tianda Pharma or the Group, stock code: 0455.HK) is pleased to announce its interim results for […]
CerbACT Asia Holds Ribbon Cutting to Celebrate New Immuno-oncology Centre of Excellence
HONG KONG, Oct 7, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Holdings Co. Ltd. (“ACT Genomics” or “the Group”) announced today that CerbACT Asia (Taipei, Taiwan), a Cerba […]
The third TDMall in the world opened in Sydney, Australia
HONG KONG, Mar 16, 2021 – (ACN Newswire via SEAPRWire.com) – TDMall (Group) Limited, a subsidiary of Tianda Pharmaceuticals Limited (listed on the main board of the Hong Kong Stock […]
NEC Joins the CONNECT Landmark Public-private Initiative for Precision Cancer Medicine
TOKYO, Mar 8, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) today announced that it has joined a landmark public-private initiative, the Norwegian Precision Cancer Medicine Implementation […]
Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
HONG KONG, Mar 4, 2021 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, together with its subsidiaries as the “Group”, Stock Code: 455.HK) is pleased to announce […]
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
SHANGHAI, CHINA, Oct 14, 2020 – (ACN Newswire) – Hua Medicine (the “Company”, Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder (“MAH”) system, […]